Cargando...

Intravitreal bevacizumab for the treatment of nonarteritic anterior ischemic optic neuropathy: a prospective trial

PURPOSE: There is currently no accepted treatment for Nonarteritic Anterior Ischemic Optic Neuropathy (NAION). One new therapeutic approach involves decreasing optic nerve edema with intravitreal bevacizumab in order to resolve a proposed compartment syndrome. METHODS: In this non-randomized control...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Rootman, D B, Gill, H S, Margolin, E A
Formato: Artigo
Lenguaje:Inglês
Publicado: Nature Publishing Group 2013
Materias:
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3626001/
https://ncbi.nlm.nih.gov/pubmed/23370417
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/eye.2012.296
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!